Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a common anxiety drug tame TBI-Related anger?

NCT ID NCT01821690

First seen Nov 20, 2025 · Last updated Jun 20, 2026 · Updated 25 times

Summary

This completed Phase 4 trial tested whether buspirone, a drug used for anxiety, can reduce irritability and aggression in people who have had a traumatic brain injury. 81 adults aged 18-70 with a closed head injury at least 6 months prior took either buspirone or a placebo for 91 days. The study measured changes in irritability and aggression using observer ratings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Indiana University and Rehabilitation Hospital of Indiana

    Indianapolis, Indiana, 46254, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

buspirone (Buspar)

What this could lead to

If it works, this could provide a medication option to help people with traumatic brain injury manage irritability and aggression.

What could go wrong

This is a small, completed Phase 4 trial with only 81 participants. Results may not apply to everyone, and buspirone may cause side effects like dizziness or nausea.

Conditions

The condition(s) this trial relates to.

Aggression Behavior Brain Injuries, Traumatic traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.